Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 112
Filter
Add more filters

Publication year range
1.
J Vet Pharmacol Ther ; 41(1): e35-e39, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28804940

ABSTRACT

Polymyxin-B is used to treat equine systemic inflammation. Bacterial toxins other than lipopolysaccharide (LPS) contribute to systemic inflammation but the effects of polymyxin-B on these are poorly defined. Whole blood aliquots from six healthy horses diluted 1:1 with RPMI were incubated for 21 hr with 1 µg/ml of LPS, lipoteichoic acid (LTA) or peptidoglycan (PGN) in the presence of increasing concentrations of polymyxin-B (10-3000 µg/ml). A murine L929 fibroblast bioassay was used to measure TNF-α activity. Polymyxin-B significantly inhibited the effects of all three bacterial toxins. Analysis of variance showed the IC50 value for polymyxin-B for TNF-α inhibition caused by LTA (11.19 ± 2.89 µg/ml polymyxin-B) was significantly lower (p = .009) than the values for LPS (46.48 ± 9.93 µg/ml) and PGN (54.44 ± 8.97 µg/ml). There was no significant difference in IC50 values between LPS and PGN (p > .05). Maximum inhibition of TNF-α was 77.4%, 73.0% and 82.7% for LPS, PGN and LTA, respectively and was not significantly different between toxins. At the two highest concentrations of polymyxin-B, TNF-α began to increase. These data suggest that polymyxin-B may inhibit the effects of bacterial toxins other than LPS and might be a more potent inhibitor of LTA than LPS or PGN.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Toxins/pharmacology , Lipopolysaccharides/pharmacology , Peptidoglycan/pharmacology , Polymyxin B/pharmacology , Teichoic Acids/pharmacology , Tumor Necrosis Factor-alpha/metabolism , Animals , Anti-Bacterial Agents/administration & dosage , Bacterial Toxins/antagonists & inhibitors , Dose-Response Relationship, Drug , Horses/blood , Lipopolysaccharides/antagonists & inhibitors , Mice , Polymyxin B/administration & dosage , Teichoic Acids/antagonists & inhibitors , Tumor Necrosis Factor-alpha/blood
2.
BMC Pregnancy Childbirth ; 17(1): 439, 2017 12 28.
Article in English | MEDLINE | ID: mdl-29282072

ABSTRACT

BACKGROUND: Few data are available to guide biological sample collection around the time of birth for large-scale birth cohorts. We are designing a large UK birth cohort to investigate the role of infection and the developing immune system in determining future health and disease. We undertook a pilot to develop methodology for the main study, gain practical experience of collecting samples, and understand the acceptability of sample collection to women in late pregnancy. METHODS: Between February-July 2014, we piloted the feasibility and acceptability of collecting maternal stool, baby stool and cord blood samples from participants recruited at prolonged pregnancy and planned pre-labour caesarean section clinics at University College London Hospital. Participating women were asked to complete acceptability questionnaires. RESULTS: Overall, 265 women were approached and 171 (65%) participated, with ≥1 sample collected from 113 women or their baby (66%). Women had a mean age of 34 years, were primarily of white ethnicity (130/166, 78%), and half were nulliparous (86/169, 51%). Women undergoing planned pre-labour caesarean section were more likely than those who delivered vaginally to provide ≥1 sample (98% vs 54%), but less likely to provide maternal stool (10% vs 43%). Pre-sample questionnaires were completed by 110/171 women (64%). Most women reported feeling comfortable with samples being collected from their baby (<10% uncomfortable), but were less comfortable about their own stool (19% uncomfortable) or a vaginal swab (24% uncomfortable). CONCLUSIONS: It is possible to collect a range of biological samples from women around the time of delivery, and this was acceptable for most women. These data inform study design and protocol development for large-scale birth cohorts.


Subject(s)
Feces , Fetal Blood , Maternal Serum Screening Tests/methods , Patient Acceptance of Health Care , Pregnancy, Prolonged/diagnosis , Preoperative Care/methods , Specimen Handling/methods , Adult , Blood Specimen Collection/methods , Blood Specimen Collection/psychology , Cesarean Section , Feasibility Studies , Female , Humans , Longitudinal Studies , Maternal Serum Screening Tests/psychology , Pilot Projects , Pregnancy , Pregnancy, Prolonged/psychology , Preoperative Care/psychology , Specimen Handling/psychology , United Kingdom
3.
J Vet Pharmacol Ther ; 38(3): 290-6, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25407884

ABSTRACT

Despite the severity and common occurrence of equine endotoxaemia, the available anti-endotoxic treatments do not effectively target key inflammatory mechanisms such as leucocyte activation and cytokine production. In this study, four compounds with potential anti-endotoxic effects, namely rolipram, azithromycin, ethyl pyruvate and metformin, were investigated in vitro using equine whole blood stimulated with bacterial lipopolysaccharide. TNF-α and IL-1ß production were measured in plasma. Rolipram was the most potent inhibitor of cytokine production (IC50 0.84 and 4.68 µm for TNF-α and IL-1ß, respectively) with almost complete inhibition of TNF-α, but inhibited IL-1ß by only 39.46%. Azithromycin produced almost complete inhibition of both cytokines, but tended to be less potent than rolipram (IC50 10.66 and 17.4 µm for TNF-α and IL-1ß, respectively). Metformin inhibited TNF-α production with similar potency to rolipram and azithromycin (IC50 3.35 µm) but showed significantly lower efficacy (45.93%; P < 0.05), and had no inhibitory effect on IL-1ß. Ethyl pyruvate was the least potent (IC50 68.35 µm and >10 mm for TNF-α and IL-1ß production, respectively). Further work is required to investigate whether these or related compounds may have potential use in the treatment of equine endotoxaemia in vivo.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Azithromycin/therapeutic use , Endotoxemia/drug therapy , Horse Diseases/drug therapy , Metformin/therapeutic use , Pyruvates/therapeutic use , Rolipram/therapeutic use , Animals , Horses , In Vitro Techniques , Interleukin-1beta/antagonists & inhibitors , Lipopolysaccharides/pharmacology , Tumor Necrosis Factor-alpha/antagonists & inhibitors
4.
Inflamm Res ; 63(8): 637-47, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24764104

ABSTRACT

OBJECTIVE AND DESIGN: Insulin and inflammatory cytokines may be involved in equine laminitis, which might be associated with digital vascular dysfunction. This study determined the effects of TNF-α and insulin on the endothelial-dependent relaxant responses of equine digital blood vessels and on equine digital vein endothelial cell (EDVEC) cGMP production. MATERIAL: Isolated rings of equine digital arteries (EDAs) and veins (EDVs) were obtained and EDVECs were cultured from horses euthanized at an abattoir. METHODS: The effect of incubation with TNF-α (10 ng/ml) and/or insulin (1,000 µIU/ml) for 1.5 h or overnight under hyperoxic and hypoxic conditions on carbachol (endothelium-dependent) induced relaxation was assessed. The time course and concentration dependency of the effect of TNF-α and the effect of insulin (1,000 µIU/ml) on EDVEC cGMP production was determined. RESULTS: Incubation of EDAs overnight with TNF-α under hypoxic conditions resulted in endothelial-dependent vascular dysfunction. EDVs produced a more variable response. TNF-α increased EDVEC cGMP formation in a time- and concentration-dependent manner. Insulin had no significant effects. CONCLUSIONS: There is a mismatch between the results obtained from isolated vessel rings and cultured endothelial cells suggesting TNF-α may reduce the biological effect of NO by reducing its bioavailability rather than its formation, leading to endothelial cell dysregulation.


Subject(s)
Arteries/drug effects , Endothelial Cells/drug effects , Insulin/pharmacology , Tumor Necrosis Factor-alpha/pharmacology , Veins/drug effects , Animals , Arteries/physiology , Carbachol , Cells, Cultured , Cyclic GMP/metabolism , Endothelial Cells/metabolism , Horses , Hyperoxia/physiopathology , Hypoxia/physiopathology , In Vitro Techniques , Metatarsophalangeal Joint , Vasodilation/drug effects , Veins/physiology
5.
J Vet Pharmacol Ther ; 36(3): 267-74, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22762272

ABSTRACT

The underlying pathophysiological triggers for equine acute laminitis are unknown, although digital vasoconstriction, ischaemia, hypoxia and reperfusion injury may be involved. The contractile responses of isolated equine digital arteries (EDAs), harvested from the hindlimbs of normal horses postmortem at an abattoir, were studied acutely (up to 3 h) under hyperoxic (95% oxygen, 5% CO2 ) and hypoxic (95% nitrogen, 5% CO2 ) conditions in organ baths. Phenylephrine (PHE; 10(-6) m), 5-hydroxytryptamine (5-HT; 10(-7) m) and high potassium (K(+) ; 118 mm) caused contraction in EDAs which was significantly (P<0.0001) enhanced under hypoxic conditions. In contrast, contraction stimulated by 9,11-dideoxy-9α,11α-epoxymethanoprostaglandin F2α (U44069; 3 × 10(-8) m) was not significantly enhanced by hypoxia (P=0.75). Hypoxia-enhanced contraction in response to K(+) was greater (P<0.03) in vessels with a functional endothelium than in vessels in which the endothelium was removed by rubbing. Fasudil (10(-6) to 10(-5) m), a Rho kinase inhibitor, and apocynin (10(-3) to 3 × 10(-3) m), an NADPH oxidase inhibitor, significantly (P ≤ 0.05) inhibited hypoxia-enhanced contraction in response to PHE and 5-HT. In conclusion, hypoxia-enhanced contraction occurred in EDAs. This appears to be partially mediated by reactive oxygen species produced by NAPDH oxidase, which activate Rho kinase to increase calcium sensitisation and enhance smooth muscle contraction.


Subject(s)
Arteries/enzymology , Hindlimb/blood supply , Horses/physiology , Oxygen/metabolism , Reactive Oxygen Species/metabolism , Vasoconstriction/drug effects , rho-Associated Kinases/metabolism , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology , Amides/pharmacology , Animals , Arteries/drug effects , Cadaver , NADPH Oxidases/antagonists & inhibitors , Phenylephrine/pharmacology , Pyridines/pharmacology , Vasoconstriction/physiology , rho-Associated Kinases/antagonists & inhibitors , rho-Associated Kinases/genetics
6.
Vet J ; 296-297: 105995, 2023.
Article in English | MEDLINE | ID: mdl-37207985

ABSTRACT

Plasma adrenocorticotropic hormone (ACTH) concentration is commonly measured to diagnose pituitary pars intermedia dysfunction (PPID). Several intrinsic and extrinsic factors affect ACTH concentrations, including breed. The objective of this study was to prospectively compare plasma ACTH concentrations among different breeds of mature horses and ponies. Three breed groups comprised Thoroughbred horses (n = 127), Shetland ponies (n = 131) and ponies of non-Shetland breeds (n = 141). Enrolled animals did not show any signs of illness, lameness or clinical signs consistent with PPID. Blood samples were collected 6 months apart, around the autumn equinox and spring equinox, and plasma concentrations of ACTH were measured by chemiluminescent immunoassay. Pairwise breed comparisons within each season were performed on log transformed data using the Tukey test. Estimated mean differences in ACTH concentrations were expressed as fold difference with 95 % confidence intervals (CI). Reference intervals for each breed group per season were calculated using non-parametric methods. In autumn, higher ACTH concentrations were found among non-Shetland pony breeds compared with Thoroughbreds (1.55 fold higher; 95 % CI, 1.35-1.77; P < 0.001), and in Shetland ponies compared with Thoroughbreds (2.67 fold higher; 95 % CI, 2.33-3.08; P < 0.001) and non-Shetland pony breeds (1.73 fold higher; 95 % CI, 1.51-1.98; P < 0.001). In spring, no differences were identified among breed groups (all P > 0.05). Reference intervals were similar among breed groups in spring, but upper limits for ACTH concentrations were markedly different between Thoroughbred horses and pony breeds in autumn. These findings emphasise that breed should be accounted for when determining and interpreting reference intervals for ACTH concentrations among healthy horses and ponies in autumn.


Subject(s)
Horse Diseases , Pituitary Diseases , Horses/genetics , Animals , Horse Diseases/genetics , Pituitary Diseases/genetics , Pituitary Diseases/veterinary , Adrenocorticotropic Hormone , Seasons , Gait
8.
Domest Anim Endocrinol ; 74: 106530, 2021 01.
Article in English | MEDLINE | ID: mdl-32818904

ABSTRACT

Although it is understood that equine endocrinopathic laminitis can be triggered by high concentrations of insulin, it is unclear whether this represents a direct action on lamellar tissue via insulin receptors (InsR), an interaction with IGF-1 receptors (IGF-1R), or some other, indirect action. This uncertainty is because of the reported scarcity of InsR in lamellar tissue and the low affinity of insulin for equine IGF-1R. In the present study, the effects of insulin and IGF-1 (as a positive control) were examined using lamellar explants isolated from the hooves of healthy horses and incubated in cell culture medium for between 2 min and 48 h. In this system, a low physiological concentration of IGF-1 (10 nM; 1.31 ng/mL) caused a marked increase in the appearance of phosphorylated IGF-1R after 5 min (P < 0.05), and this effect was blocked by a human anti-IGF-1R monoclonal antibody (mAb). However, a high concentration of insulin (10 nM; 1,430 µIU/mL) appeared to cause dephosphorylation of the IGF-1R after 5 min (P < 0.01), 15 min, and 30 min (P < 0.001). Using 3H-thymidine as a marker, it was also demonstrated that insulin and IGF-1-stimulated cell proliferation in lamellar explants over the same concentration range as each other (1-100 nM), implying that each peptide acts via its own receptor (P < 0.001). Conversely, the effect of both peptides could be blocked using a selective anti-IGF-1R mAb (P < 0.001), implying that insulin acts via IGF1-R (either directly or indirectly). Notwithstanding this conundrum, the results demonstrate that insulin acts directly on lamellar tissue and suggest that a therapeutic anti-IGF-1R mAb could be useful in treating or preventing endocrinopathic laminitis.


Subject(s)
Gene Expression Regulation/drug effects , Hoof and Claw/metabolism , Horses/metabolism , Insulin/pharmacology , Receptor, IGF Type 1/metabolism , Tissue Culture Techniques/veterinary , Animals , Antibodies, Monoclonal , Blotting, Western , Cell Proliferation , Receptor, IGF Type 1/genetics
9.
Inflamm Res ; 59(9): 689-98, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20237827

ABSTRACT

OBJECTIVE AND DESIGN: Hypoxia may enhance the deleterious effects of lipopolysaccharide (LPS) in the endotoxaemic horse. This study has examined some of the actions of LPS and hypoxia, alone and in combination, on cultured equine digital vein endothelial cells (EDVEC) and the signalling molecules involved. METHODS: EDVEC were exposed to LPS, 5% O(2) and LPS then 5% O(2) for up to 24 h. HIF-1alpha stabilisation, neutrophil adhesion and EDVEC permeability were assessed by immunoblotting, measurement of myeloperoxidase and movement of FITC-dextran, respectively. Pharmacological inhibitors were used to assess the roles of p38 MAPK and HIF-1alpha. RESULTS: LPS and hypoxia significantly increased HIF-1alpha stabilisation, neutrophil adhesion and EDVEC permeability and the effects of the two stimuli in combination on HIF-1alpha stabilisation and neutrophil adhesion were more than additive. The effect of LPS, but not 5% O(2), on neutrophil adherence required activation of p38 MAPK, whereas EDVEC permeability in response to both stimuli was dependent on p38 MAPK and HIF-1alpha. CONCLUSIONS: Exposure of EDVEC to LPS prior to induction of hypoxia up-regulates responses that may enhance LPS-induced tissue damage in the endotoxaemic horse. Inhibitors of p38 MAPK or HIF-1alpha could reduce such unwanted effects.


Subject(s)
Endothelial Cells/metabolism , Endotoxemia/veterinary , Horse Diseases/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Hypoxia/veterinary , Animals , Capillary Permeability/drug effects , Cell Adhesion/drug effects , Cell Hypoxia/drug effects , Cells, Cultured , Endothelial Cells/drug effects , Endotoxemia/metabolism , Female , Horses , Hypoxia/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/chemistry , Lipopolysaccharides/toxicity , Male , Neutrophils/drug effects , Up-Regulation/drug effects , p38 Mitogen-Activated Protein Kinases/analysis
10.
Aust Vet J ; 98(12): 616-621, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33001453

ABSTRACT

OBJECTIVE: To compare circannual plasma concentrations of adrenocorticotropic hormone (ACTH) and seasonal dexamethasone suppression test (DST) results between three different equine breed groups. METHODS: Six Standardbred horses, six Andalusian horses and six mixed-breed ponies were followed over a 1-year period, during which time groups were managed identically. Blood samples were collected monthly (around the autumn equinox) or in every second month (other times of the year) for the determination of plasma ACTH concentrations using a chemiluminescent immunoassay. Overnight DSTs were performed quarterly, with suppression of plasma cortisol to below 27 nmol/L at 19 h considered a normal result. RESULTS: Seasonal variation in plasma ACTH concentrations was present among all breed groups with, as expected, higher levels detected around the autumn equinox, from February to April (P < 0.001). Plasma ACTH concentrations were different between breed groups in March, with higher levels in Andalusians compared with Standardbreds (P = 0.048) and in ponies compared with Standardbreds (P = 0.010). Suppression of cortisol during the DST was normal for all animals in winter, spring and summer, but five Andalusians and three ponies returned abnormally high results in autumn, compared with zero Standardbreds. CONCLUSION: Higher plasma ACTH concentrations and more false-positive DST results were obtained during autumn in ponies and Andalusian horses when compared with Standardbred horses. Potential differences between breeds should be considered when interpreting test results for horses and ponies that are evaluated for pituitary pars intermedia dysfunction. Further work is recommended to establish population-based reference intervals and clinical cut-off values for ACTH in different equine breeds.


Subject(s)
Horse Diseases , Pituitary Diseases , Adrenocorticotropic Hormone , Animals , Breeding , Dexamethasone , Horses , Hydrocortisone , Pituitary Diseases/veterinary
11.
Vet Immunol Immunopathol ; 129(3-4): 167-73, 2009 Jun 15.
Article in English | MEDLINE | ID: mdl-19091426

ABSTRACT

The link between the fermentation of carbohydrate in the equine large intestine and the development of acute laminitis is poorly understood. Absorption of endotoxin (lipopolysaccharide; LPS) into the plasma has been observed in one experimental model of laminitis, but does not cause laminitis when administered alone. Thus, the potential role of endotoxin is unclear. Platelet activation has previously been demonstrated in the developmental stage of laminitis. Equine platelets are more sensitive than leukocytes to activation by endotoxin, and can be activated directly by LPS in the low pg/ml range, activating p38 MAP kinase and releasing serotonin (5-HT) and thromboxane. The objectives of this study were firstly to determine whether endotoxin and platelet activation could be measured in the plasma of horses in the developmental phase of laminitis induced with oligofructose. Secondly, the time course of events involving platelet activation and platelet-derived vasoactive mediator production was investigated. Laminitis was induced in six Standardbred horses by the administration of 10 g/kg bwt of oligofructose. Plasma samples were obtained every 4h, and platelet pellets were obtained by centrifugation. LPS was measured using a kinetic limulus amebocyte lysate assay, and platelet activation was assessed by Western blotting for the phosphorylated form of p38 MAP kinase. Plasma 5-HT was assayed by HPLC with electrochemical detection and thromboxane B(2) was measured by radioimmunoassay. Clinical signs of laminitis and histopathologic changes were observed in lamellar sections from five of the six horses. Onset of lameness was between 20 and 30 h after the administration of oligofructose. LPS increased above the limit of detection (0.6 pg/ml) to reach a peak of 2.4+/-1.0 pg/ml at 8 h. TNFalpha was also detectable in the plasma from 12 to 24 h. There was a time-dependent increase in platelet p38 MAPK phosphorylation, which peaked at approximately 12 h (3.8+/-1.3 fold increase); plasma 5-HT and thromboxane increased steadily after this time (2.9+/-0.6 and 11.3+/-5.0 fold increases, respectively). These data indicate that small quantities of endotoxin may move into the circulation from the large intestine after the sharp decrease in pH that occurs as a result of carbohydrate fermentation. Correlating these findings with in vitro studies suggests that LPS may primarily activate platelets, leading indirectly to the activation of leukocytes. Therefore, endotoxin may contribute in the initiation of the early inflammatory changes observed in experimental models of acute laminitis.


Subject(s)
Endotoxins/blood , Foot Diseases/veterinary , Hoof and Claw , Horse Diseases/chemically induced , Oligosaccharides/toxicity , Platelet Activation/immunology , Animals , Female , Foot Diseases/blood , Foot Diseases/chemically induced , Horse Diseases/blood , Horses , Inflammation/blood , Inflammation/chemically induced , Inflammation/veterinary , Male , Serotonin/blood , Thromboxane B2/blood , Tumor Necrosis Factor-alpha/blood
12.
J Vet Pharmacol Ther ; 32(2): 189-96, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19290950

ABSTRACT

Lipopolysaccharide (LPS) can activate equine platelets directly or indirectly, via leukocyte-derived platelet activating factor (PAF). Thromboxane (Tx) production by LPS-stimulated equine platelets requires p38 MAPK and this kinase has been suggested as a therapeutic target in endotoxaemia. The present study has utilised selective inhibitors to investigate the role of p38 MAPK and two other kinases, phosphatidylinositol-3 kinase (PI3K) and protein kinase C (PKC), in regulating PAF-induced Tx production, aggregation and 5-HT release in equine platelets, and the modification of these responses by LPS. LPS enhanced PAF-induced 5-HT release, an effect that was reduced by the p38 MAPK inhibitor, SB203580 (60 +/- 8% reduction; n = 6). SB203580 did not affect responses to PAF alone; whereas inhibition of PKC reduced PAF-induced 5-HT release, Tx production and aggregation (maximal inhibition by the PKCdelta inhibitor, rottlerin: 69 +/- 13%, 63 +/- 14% and 97 +/- 1%, respectively; n = 6). Wortmannin and LY249002, which inhibit PI3K, also caused significant inhibition of PAF-induced aggregation (maximal inhibition 78 +/- 3% and 88 +/- 2%, respectively; n = 6). These data suggest that inhibition of platelet p38 MAPK may be of benefit in equine endotoxaemia by counteracting some of the effects of LPS. However, detrimental effects of platelet activation mediated by PAF and not enhanced by LPS are unlikely to be markedly affected.


Subject(s)
Horses/blood , Phosphotransferases/metabolism , Platelet Activating Factor/pharmacology , Platelet Activation/physiology , Analysis of Variance , Animals , Lipopolysaccharides/pharmacology , Phosphatidylinositol 3-Kinases/metabolism , Phosphotransferases/antagonists & inhibitors , Platelet Activation/drug effects , Protein Kinase C/metabolism , Serotonin/blood , Thromboxanes/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism
13.
J Hosp Infect ; 70(1): 66-70, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18602192

ABSTRACT

Surgeons frequently sustain needlestick injuries when operating. The aim of this study was to evaluate the incidence and reporting rate of needlestick injuries at one institution. A questionnaire was distributed anonymously to 69 surgeons of all grades and specialties in a district general hospital in the UK. The questionnaire was returned by 42 surgeons (60.9%). There were 840 needlestick injuries over two years, of which 126 caused bleeding. Senior surgeons who spent more hours operating per week had a higher rate of needlestick injuries compared with junior surgeons (29.1 vs 6.59 injuries per surgeon over two years). Of the total number of injuries, 19 (2.26%) were reported to Occupational Health according to the surgeons questioned, but only six reported incidents were found in the Occupational Health records. Junior surgeons were significantly more likely to report needlestick injuries than senior surgeons (9.82% vs 1.10% of injuries reported, P=0.0000045). The main reasons for failure to report needlestick injuries were due to the lack of time and excessive paperwork. Seventy-three percent of surgeons did not routinely use double gloves when operating, mainly because of decreased hand sensation. The rate of needlestick injury reporting by surgeons at this institution is extremely low. Previous studies have shown a higher reporting rate suggesting that, despite awareness of blood-borne infections, surgeons are still not following recommended protocols.


Subject(s)
Accidents, Occupational/statistics & numerical data , Needlestick Injuries/epidemiology , Risk Management/statistics & numerical data , Adult , Age Factors , Guideline Adherence , Hospitals , Humans , Incidence , Middle Aged , Surveys and Questionnaires , United Kingdom
14.
Aust Vet J ; 96(7): 233-242, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29862508

ABSTRACT

The purpose of this article is to provide a review of the current knowledge and opinions about the epidemiology, clinical findings (including sequelae), diagnosis, treatment and monitoring of equine pituitary pars intermedia dysfunction, particularly in the Australian context. This information and the recommendations provided will assist practitioners in making informed decisions regarding the diagnosis and management of this disorder.


Subject(s)
Horse Diseases , Pituitary Diseases/veterinary , Pituitary Gland, Intermediate , Adrenocorticotropic Hormone/blood , Animals , Australia/epidemiology , Dopamine Agonists/therapeutic use , Horse Diseases/diagnosis , Horse Diseases/drug therapy , Horse Diseases/epidemiology , Horse Diseases/physiopathology , Horses , New Zealand/epidemiology , Pergolide/therapeutic use , Pituitary Diseases/diagnosis , Pituitary Diseases/drug therapy , Pituitary Diseases/epidemiology , Pituitary Gland, Intermediate/physiopathology , Practice Guidelines as Topic , Risk Factors , Societies, Scientific
15.
Res Vet Sci ; 82(3): 332-4, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17107696

ABSTRACT

Platelets contribute to the pathogenesis of human allergic airway disease. The aim of this study was to compare platelet activating factor (PAF)-induced platelet aggregation and thromboxane (Tx) production, plasma Tx and 5-hydroxytryptamine (5-HT) in ponies with recurrent airway obstruction (RAO), an hypersensitivity to inhaled antigens, and normal ponies, before and after antigen exposure. Plasma 5-HT was significantly higher in ponies with RAO but was not further increased by antigen challenge. There was no difference between PAF-induced platelet aggregation or Tx production, or in plasma Tx before or after challenge. These data suggest there may be a difference between platelet 5-HT uptake in RAO and normal ponies but do not provide evidence of platelet activation following antigen exposure.


Subject(s)
Blood Platelets/metabolism , Horse Diseases/physiopathology , Hypersensitivity/veterinary , Lung Diseases, Obstructive/veterinary , Animals , Antigens , Horses , Lung Diseases, Obstructive/physiopathology , Platelet Activating Factor/metabolism , Platelet Aggregation/physiology , Serotonin/metabolism , Thromboxanes/metabolism , Time Factors
16.
J Small Anim Pract ; 48(4): 202-8, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17381765

ABSTRACT

BACKGROUND: Systemic hypertension is an important problem in older cats associated with kidney disease and hypokalaemia, suggesting that excessive activity of the renin-angiotensin-aldosterone system might contribute to the hypertensive state. Fluctuations in plasma renin activity and plasma aldosterone concentrations complicate the interpretation of these assays. OBJECTIVES: The aim of this study was to determine whether measurement of urinary aldosterone excretion in cats aided the investigation of hypertension. METHODS: Urine concentrations of free (ethyl acetate extract) and 18-glucuronidated aldosterone (acid hydrolysis before extraction) were measured by radioimmunoassay in normal, normotensive and hypertensive azotaemic cats (n=11 per group). Urine samples from 11 healthy human volunteers and eight normal dogs were also analysed for comparison. Urinary aldosterone concentration was corrected for the urinary creatinine concentration. RESULTS: Cats excreted 7.3 times less free aldosterone than human beings, and no free aldosterone was detected in dog urine. Acid hydrolysis led to large increases in aldosterone recovery from both human beings and dog but not feline urine. No significant effect of hypertension or azotaemia on feline urinary aldosterone concentration was found. CLINICAL SIGNIFICANCE: Measurement of aldosterone in feline urine using the available methodology has limited or no utility in investigating feline hypertension.


Subject(s)
Aldosterone/urine , Cat Diseases/urine , Hypertension, Renal/veterinary , Adult , Animals , Cat Diseases/diagnosis , Cats , Dogs , Female , Humans , Hypertension, Renal/diagnosis , Hypertension, Renal/urine , Male , Species Specificity
17.
Vaccine ; 35(32): 3917-3921, 2017 07 13.
Article in English | MEDLINE | ID: mdl-28645716

ABSTRACT

In 2013, the Council for International Organizations of Medical Sciences (CIOMS) created a Working Group on Vaccine Safety (WG) to address unmet needs in the area of vaccine pharmacovigilance. Generating reliable data about specific vaccine safety concerns is becoming a priority due to recent progress in the development and deployment of new vaccines of global importance, as well as novel vaccines targeting diseases specifically endemic to many resource-limited countries (RLCs), e.g. malaria, dengue. The WG created a Guide to Active Vaccine Safety Surveillance (AVSS) to assist national regulatory authorities and national immunization program officers in RLCs in determining the best course of action with regards to non-routine pharmacovigilance activities, when confronted with a launch of a new vaccine or a vaccine that is new to their country. Here we summarize the results of the WG, further detailed in the Guide, which for the first time provides a structured approach to identifying and analyzing specific vaccines safety knowledge gaps, while considering all available sources of information, in order to determine whether AVSS is an appropriate solution. If AVSS is confirmed as being the appropriate tool, the Guide provides additional essential information on AVSS, a detailed overview of common types of AVSS and practical implementation considerations. It also provides a framework for a well-constructed and informative AVSS when needed, thus aiming to ensure the best possible safety of immunization in this new landscape.


Subject(s)
Drug-Related Side Effects and Adverse Reactions/epidemiology , Pharmacovigilance , Vaccines/administration & dosage , Vaccines/adverse effects , Humans
18.
Aust Vet J ; 95(10): 370-374, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28948628

ABSTRACT

OBJECTIVES: The aims of this study were to (1) report the incidence of laminitis among a population of horses and ponies attending Pony Clubs in Victoria, Australia, and (2) describe the dietary and management practices of the sample population. METHODS: Researchers visited 10 Pony Clubs over a 10-month period. Horse and pony owners completed a questionnaire to provide information on management relating to diet and exercise. Owners were also asked to report their animal's history of laminitis, if any. RESULTS: From a survey population of 233 horses and ponies, 15.0% of animals (35 individuals) were reported to have suffered from at least one episode of laminitis. Of the animals that had suffered from laminitis, more than half had experienced multiple episodes. The majority of previously laminitic horses and ponies (71.4%) had not experienced an episode of laminitis within the past 12 months; however, 14.2% had experienced an incident within the past month. The proportion of ponies affected by laminitis (31/142; 21.8%) was significantly higher (P < 0.001) than the proportion of horses affected by laminitis (4/91; 4.4%). The incidence of laminitis within the pony group sampled was 6.5 cases per 100 pony years, while the incidence in horses was 0.55 cases per 100 horse years. CONCLUSION: This study provided information on the incidence of laminitis in the general population of pleasure horses and ponies in south-eastern Australia. It also provided an overview of dietary and management practices. Given the high incidence of animals that had been affected by laminitis (and the associated welfare implications), this study highlights the importance of owner education regarding appropriate feeding and management strategies to reduce the risk of laminitis.


Subject(s)
Animal Husbandry/methods , Foot Diseases/veterinary , Horse Diseases/epidemiology , Animals , Female , Foot Diseases/epidemiology , Horses , Incidence , Male , South Australia/epidemiology , Surveys and Questionnaires , Victoria
19.
Contemp Clin Trials ; 52: 35-38, 2017 01.
Article in English | MEDLINE | ID: mdl-27836506

ABSTRACT

Primary care patient-centered medical homes (PCMHs) are an effective healthcare delivery model. Evidence regarding the most effective payment models for increased coordination efforts is sparse. This protocol paper describes the evaluation of an Alternative Payment Methodology (APM) implemented in a subset of Oregon community health centers (CHCs), using a prospective matched observational design. The APM is a primary care payment reform intervention that changed Oregon's Medicaid payment for several CHCs from fee-for-service reimbursement to a per-member-per-month capitated payment. We will implement a difference-in-difference analytic approach to evaluate pre-post APM changes between intervention and control groups, including: 1) clinic-level outcomes, 2) patient-level clinical outcomes, and 3) patient-level econometric outcomes. Findings from the project will be of national significance, as there is a need for evidence regarding how novel payment methods might enhance PCMH capabilities and support their capacity to produce better quality and outcomes. If this capitated payment method is proven effective, study findings will inform dissemination of similar APMs nationwide.


Subject(s)
Capitation Fee , Community Health Centers/organization & administration , Patient-Centered Care/organization & administration , Primary Health Care/organization & administration , Community Health Centers/economics , Fee-for-Service Plans , Humans , Medicaid , Oregon , Patient-Centered Care/economics , Primary Health Care/economics , Prospective Studies , Reimbursement Mechanisms , United States
20.
Circ Res ; 94(10): 1367-74, 2004 May 28.
Article in English | MEDLINE | ID: mdl-15087420

ABSTRACT

Cold-induced vasoconstriction in cutaneous blood vessels is mediated in part by increased activity of vascular smooth muscle alpha2-adrenoceptors (VSM alpha2-ARs). In mouse cutaneous arteries, alpha2C-ARs are normally silent at 37 degrees C but mediate cold-induced augmentation of alpha2-AR responsiveness. In transfected HEK293 cells, this functional rescue is mediated by cold-induced translocation of alpha2C-ARs from the Golgi to the plasma membrane. Experiments were performed to determine the role of Rho/Rho kinase signaling in this process. Inhibition of Rho kinase (fasudil, Y27632 or H-1152) did not affect constriction of isolated mouse tail arteries to the alpha2-AR agonist UK 14 304 at 37 degrees C but dramatically reduced the augmented responses to the agonist at 28 degrees C. After Rho kinase inhibition, cooling no longer increased constriction evoked by alpha2-AR stimulation. Cooling (to 28 degrees C) activated Rho in VSM cells and increased the calcium sensitivity of constriction in alpha toxin-permeabilized arteries. Stimulation of alpha2-ARs in VSM cells had no effect on Rho activity or calcium sensitivity at 37 degrees C or 28 degrees C. In HEK293 cells transfected with alpha2C-ARs, cooling (to 28 degrees C) stimulated the translocation of alpha2C-ARs to the plasma membrane and this effect was prevented by inhibition of Rho kinase, using fasudil or RNA interference. Consistent with inhibition of the spatial rescue of alpha2C-ARs, fasudil inhibited alpha2-AR-mediated mobilization of calcium in tail arteries at 28 degrees C but not 37 degrees C. Therefore, cold-induced activation of Rho/Rho kinase can mediate cold-induced constriction in cutaneous arteries by enabling translocation of alpha2C-ARs to the plasma membrane and by increasing the calcium sensitivity of the contractile process.


Subject(s)
Cold Temperature , Protein Serine-Threonine Kinases/physiology , Receptors, Adrenergic, alpha-2/metabolism , Skin/blood supply , Vasoconstriction , Animals , Arteries/enzymology , Arteries/metabolism , Arteries/physiology , Enzyme Inhibitors/pharmacology , Intracellular Signaling Peptides and Proteins , Male , Mice , Mice, Inbred C57BL , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Transport , Receptors, Adrenergic, alpha-2/physiology , Signal Transduction , Vasoconstriction/drug effects , rho GTP-Binding Proteins/metabolism , rho-Associated Kinases
SELECTION OF CITATIONS
SEARCH DETAIL